Nonalcoholic Fatty Liver Disease and the Gut Microbiome - Université d'Angers Accéder directement au contenu
Article Dans Une Revue Clinics in Liver Disease Année : 2016

Nonalcoholic Fatty Liver Disease and the Gut Microbiome

Résumé

Recent progress has allowed a more comprehensive study of the gut microbiota. Gut microbiota helps in health maintenance and gut dysbiosis associates with chronic metabolic diseases. Modulation of short-chain fatty acids and choline bioavailability, lipoprotein lipase induction, alteration of bile acid profile, endogenous alcohol production, or liver inflammation secondary to endotoxemia result from gut dysbiosis. Modulation of the gut microbiota by pre/probiotics gives promising results in animal, but needs to be evaluated in human before use in clinical practice. Gut microbiota adds complexity to the pathophysiology of nonalcoholic fatty liver disease but represents an opportunity to discover new therapeutic targets.

Fichier non déposé

Dates et versions

hal-02648803 , version 1 (29-05-2020)

Identifiants

Citer

Jérôme Boursier, Anna Mae Diehl. Nonalcoholic Fatty Liver Disease and the Gut Microbiome. Clinics in Liver Disease, 2016, 20 (2), pp.263-75. ⟨10.1016/j.cld.2015.10.012⟩. ⟨hal-02648803⟩

Collections

UNIV-ANGERS HIFIH
9 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More